The Future of Hormone Therapy: What Basic Science and Clinical Studies Teach Us, Volume 1052ISBN: 978-1-57331-585-2
Paperback
264 pages
July 2005, Wiley-Blackwell
|
Other questions explored include the following: What is the
appropriate population to study? What is the therapeutic window for
hormone therapy and/or estrogen therapy? What are the appropriate
formulations of HT and ET? What should be considered the most
appropriate design for clinical trials that address the efficacy of
HT/ET? What are appropriate surrogate markers of neurological
decline/impairment? What are the best in vitro and in vivo models
to address the efficacy of postmenopausal HT or ET?
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.
ACADEMY MEMBERS: Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit http://www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member.